Berdikari Pondasi Perkasa Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Berdikari Pondasi Perkasa Tbk trades at Rp163 (market cap 770.19B, 14.46M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Berdikari Pondasi Perkasa Tbk is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 14.46M). Which is the better fit depends on your goals.
| BDKR | PRDL | |
|---|---|---|
Market Cap | 770.19B | 470.58B |
Volume | 14.46M | 28.43M |
Lot | 144.63K | 284.34K |
Turnover | 2.35B | 7.8B |
Average Price | 162.49 | 274.19 |
Value | 2.35B | 7.8B |
Indicative Equilibrium Price | 163 | 270 |
Indicative Equilibrium Volume | 605 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Berdikari Pondasi Perkasa Tbk (the “Company”) was established on February 27, 1984 based onNotarial Deed No. 81 of Gretha Liestijawatie, S.H. The Company started its commercial operations onFebruary 27, 1984. The controlling interest of the Company is owned by an individual namely Tan John Tanuwijaya.
Read more on BDKR →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →